Copy to clipboard 
LINK is pleased to announce that on February 20, 2025, it received FDA 510(k) clearance to market the CORE Shoulder System.
This novel shoulder arthroplasty tool is designed to assist in the placement of the K-wire for the glenoid component during total shoulder replacement.
This next-generation device streamlines glenoid preparation by enabling surgeons to implant the K-wire precisely to the pre-operative plan with ease and confidence. The system can be used as soon as the CT scan is planned, enabling a lean, efficient operating room.
The compact CORE Shoulder system fits into a single portable case, and all of its sterile-field reusable components are provided in a single half-sized instrument tray. CORE operates without the need for installing bone markers, cameras, or permanent OR systems. The system tracks the live position of the handheld instrument relative to an untracked virtual anatomical model and provides targeting instructions wirelessly via a touch screen tablet.
The tool is compatible with the LINK Embrace Shoulder systems (Reverse and Anatomic TSA), integrating into the standard surgical workflow. LINK completed its first cases with CORE in June 2025, with broader availability anticipated later in the year.
“This clearance marks a pivotal step in our mission to simplify complex procedures while preserving accuracy,” Peter Willenborg, CEO of LINK Group states. “With CORE, we’re putting powerful digital targeting tools directly into the hands of surgeons—no cords, no trackers, no waiting for guides. It’s part of our commitment to making advanced technology more accessible.”
Source: Waldemar LINK
LINK is pleased to announce that on February 20, 2025, it received FDA 510(k) clearance to market the CORE Shoulder System.
This novel shoulder arthroplasty tool is designed to assist in the placement of the K-wire for the glenoid component during total shoulder replacement.
This next-generation device streamlines glenoid preparation by...
LINK is pleased to announce that on February 20, 2025, it received FDA 510(k) clearance to market the CORE Shoulder System.
This novel shoulder arthroplasty tool is designed to assist in the placement of the K-wire for the glenoid component during total shoulder replacement.
This next-generation device streamlines glenoid preparation by enabling surgeons to implant the K-wire precisely to the pre-operative plan with ease and confidence. The system can be used as soon as the CT scan is planned, enabling a lean, efficient operating room.
The compact CORE Shoulder system fits into a single portable case, and all of its sterile-field reusable components are provided in a single half-sized instrument tray. CORE operates without the need for installing bone markers, cameras, or permanent OR systems. The system tracks the live position of the handheld instrument relative to an untracked virtual anatomical model and provides targeting instructions wirelessly via a touch screen tablet.
The tool is compatible with the LINK Embrace Shoulder systems (Reverse and Anatomic TSA), integrating into the standard surgical workflow. LINK completed its first cases with CORE in June 2025, with broader availability anticipated later in the year.
“This clearance marks a pivotal step in our mission to simplify complex procedures while preserving accuracy,” Peter Willenborg, CEO of LINK Group states. “With CORE, we’re putting powerful digital targeting tools directly into the hands of surgeons—no cords, no trackers, no waiting for guides. It’s part of our commitment to making advanced technology more accessible.”
Source: Waldemar LINK
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
